Effect of calcium supplementation on bone resorption in pregnancy and the early postpartum: a randomized controlled trial in Mexican Women

Nutrition Journal

Martha M Téllez-Rojo³  Mauricio Hernández-Avila³  Howard Hu¹  Karen E Peterson²  Richard J Wood⁶  Katarzyna Kordas⁴  Adriana Mercado-García³  Héctor Lamadrid-Figueroa³  Adrienne S Ettinger⁵ 

[1] Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada;Department of Environmental Health Sciences, Human Nutrition Program, University of Michigan School of Public Health, Ann Arbor, MI, USA;National Institute of Public Health, Universidad 655 Colonia Santa María Ahuacatitlán, C.P. 62100 Cuernavaca, Morelos, Mexico;School of Social and Community Medicine, University of Bristol, Bristol, England, UK;Center for Perinatal, Pediatric, and Environmental Epidemiology, Yale Schools of Public Health and Medicine, 1 Church Street 6th floor, New Haven, CT 06510, USA;Department of Nutrition, University of Massachusetts at Amherst, Amherst, MA, USA

关键词: Urinary N-telopeptide of type I collagen;    Quantitative ultrasound bone speed of sound;    Pregnancy;    Lactation;    Clinical trials;    Calcium;    Bone-specific alkaline phosphatase;   

Others  :  1132391
DOI  :  10.1186/1475-2891-13-116

 received in 2014-08-09, accepted in 2014-12-11,  发布年份 2014

【 摘 要 】

Background

Calcium needs are physiologically upregulated during pregnancy and lactation to meet demands of the developing fetus and breastfeeding infant. Maternal calcium homeostasis is maintained by hormonal adaptive mechanisms, thus, the role of dietary calcium supplementation in altering maternal responses to fetal-infant demand for calcium is thought to be limited. However, increased calcium absorption is directly related to maternal calcium intake and dietary supplementation has been suggested to prevent transient bone loss associated with childbearing.

Methods

In a double-blind, randomized placebo-controlled trial, we randomly assigned 670 women in their first trimester of pregnancy to 1,200 mg/day calcium (N = 334) or placebo (N = 336). Subjects were followed through 1-month postpartum and the effect on urinary cross-linked N-telopeptides (NTx) of type I collagen, a specific marker of bone resorption, was evaluated using an intent-to-treat analysis. Women with a baseline and at least one follow-up measurement (N = 563; 84%) were included. Subsequent analyses were conducted stratifying subjects by compliance assessed using pill counts. In random subsets of participants, bone-specific alkaline phosphatase (BAP) (N = 100) and quantitative ultrasound (QUS) (N = 290) were also measured.

Results

Calcium was associated with an overall reduction of 15.8% in urinary NTx relative to placebo (p < 0.001). Among those who consumed ≥50%, ≥67%, and ≥75% of pills, respectively, the effect was associated with 17.3%, 21.3%, and 22.1% reductions in bone resorption (all p < 0.001). There was no significant effect of calcium on bone formation measured by BAP. However, by 1-month postpartum, those in the calcium group had significantly lower NTx/BAP ratios than those in the placebo group (p = 0.04) indicating a net reduction in bone loss in the supplement group by the end of follow-up. Among subjects who consumed ≥50% and ≥75% of pills, respectively, calcium was also associated with an increase of 26.3 m/s (p = 0.03) and 59.0 m/s (p = 0.009) in radial SOS relative to placebo by 1-month postpartum.

Conclusions

Calcium administered during pregnancy and the early postpartum period, to women with intakes around adequacy, was associated with reduced bone resorption and, thus, may constitute a practical intervention to prevent transient skeletal loss associated with childbearing.

Trial registration

ClinicalTrials.gov Identifier NCT00558623

【 授权许可】

   
2014 Ettinger et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Prentice A: Calcium in pregnancy and lactation. Annu Rev Nutr 2000, 20:249-272.
• [2]Hacker AN, Fung EB, King JC: Role of calcium during pregnancy: maternal and fetal needs. Nutr Rev 2012, 70:397-409.
• [3]Kovacs CS: Calcium and bone metabolism in pregnancy and lactation. J Clin Endocrinol Metab 2001, 86:2344-2348.
• [4]Kovacs CS, Kronenberg HM: Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 1997, 18:832-872.
• [5]Cross NA, Hillman LS, Allen SH, Krause GF, Vieira NE: Calcium homeostasis and bone metabolism during pregnancy, lactation, and postweaning: a longitudinal study. Am J Clin Nutr 1995, 61:514-523.
• [6]Ritchie LD, Fung EB, Halloran BP, Turnlund JR, Van Loan MD, Cann CE, King JC: A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses. Am J Clin Nutr 1998, 67:693-701.
• [7]Sowers M, Corton G, Shapiro B, Jannausch ML, Crutchfield M, Smith ML, Randolph JF, Hollis B: Changes in bone density with lactation. JAMA 1993, 269:3130-3135.
• [8]Sowers MF, Scholl T, Harris L, Jannausch M: Bone loss in adolescent and adult pregnant women. Obstet Gynecol 2000, 96:189-193.
• [9]Kalkwarf HJ, Specker BL: Bone mineral changes during pregnancy and lactation. Endocrine 2002, 17:49-53.
• [10]Purdie DW, Aaron JE, Selby PL: Bone histology and mineral homeostasis in human pregnancy. Br J Obstet Gynaecol 1988, 95:849-854.
• [11]Naylor KE, Iqbal P, Fledelius C, Fraser RB, Eastell R: The effect of pregnancy on bone density and bone turnover. J Bone Miner Res 2000, 15:129-137.
• [12]Yamaga A, Taga M, Minaguchi H: Changes in urinary excretions of C-telopeptide and cross-linked N-telopeptide of type I collagen during pregnancy and puerperium. Endocr J 1997, 44:733-738.
• [13]Pagani F, Francucci CM, Moro L: Markers of bone turnover: biochemical and clinical perspectives. J Endocrinol Invest 2005, 28(10 Suppl):8-13.
• [14]Hellmeyer L, Ziller V, Anderer G, Ossendorf A, Schmidt S, Hadji P: Biochemical markers of bone turnover during pregnancy: a longitudinal study. Exp Clin Endocrinol Diabetes 2006, 114:506-510.
• [15]Holroyd C, Harvey N, Dennison E, Cooper C: Epigenetic influences in the developmental origins of osteoporosis. Osteoporos Int 2012, 23:401-410.
• [16]Zhu K, Whitehouse AJ, Hart P, Kusel M, Mountain J, Lye S, Pennell C, Walsh JP: Maternal vitamin D status during pregnancy and bone mass in offspring at 20 years of age: a prospective cohort study. J Bone Miner Res 2014, 29:1088-1095.
• [17]Lawlor DA, Wills AK, Fraser A, Sayers A, Fraser WD, Tobias JH: Association of maternal vitamin D status during pregnancy with bone-mineral content in offspring: a prospective cohort study. Lancet 2013, 381:2176-2183.
• [18]Institute of Medicine: Dietary Reference Intakes for Calcium and Vitamin D. Washington DC: National Academies Press; 2011.
• [19]Avendaño-Badillo D, Hernández-Avila M, Hernández-Cadena L, Rueda-Hernández G, Solano-González M, Ibarra LG, Hu H, Téllez-Rojo MM: High dietary calcium intake decreases bone mobilization during pregnancy in humans. Salud Publica Mex 2009, 51(Suppl 1):S100-S107.
• [20]Zeni SN, Ortela Soler CR, Lazzari A, López L, Suarez M, Di Gregorio S, Somoza JI, de Portela ML: Interrelationship between bone turnover markers and dietary calcium intake in pregnant women: a longitudinal study. Bone 2003, 33:606-613.
• [21]Weisman SM, Matkovic V: Potential use of biochemical markers of bone turnover for assessing the effect of calcium supplementation and predicting fracture risk. Clin Ther 2005, 27:299-308.
• [22]Olausson H, Goldberg GR, Laskey MA, Schoenmakers I, Jarjou LM, Prentice A: Calcium economy in human pregnancy and lactation. Nutr Res Rev 2012, 25:40-67.
• [23]Janakiraman V, Ettinger A, Mercado-Garcia A, Hu H, Hernandez-Avila M: Calcium supplements and bone resorption in pregnancy: a randomized crossover trial. Am J Prev Med 2003, 24:260-264.
• [24]Jarjou LM, Laskey MA, Sawo Y, Goldberg GR, Cole TJ, Prentice A: Effect of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake. Am J Clin Nutr 2010, 92:450-457.
• [25]Liu Z, Qiu L, Chen YM, Su YX: Effect of milk and calcium supplementation on bone density and bone turnover in pregnant Chinese women: a randomized controlled trial. Arch Gynecol Obstet 2011, 283:205-211.
• [26]U.S. Pharmacopeia: USP Dietary Supplements Compendium. Rockville MD: U.S. Pharmacopeia; 2012.
• [27]Zhu YI, Haas JD: Response of serum transferrin receptor to iron supplementation in iron-depleted, nonanemic women. Am J Clin Nutr 1998, 67:271-275.
• [28]Institute of Medicine: Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. In Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board. Washington DC: National Academy Press; 1997.
• [29]National Research Council: Recommended Dietary Allowances. In Subcommittee on the Tenth Edition of the RDAs. Food and Nutrition Board. Commission on Life Sciences. 10th edition. Washington DC: National Academy Press; 1989.
• [30]Institute of Medicine: Nutrition During Pregnancy: Part II: Nutrient Supplements. In Subcommittee on Dietary Intake and Nutrient Supplements During Pregnancy. Committee on Nutritional Status During Pregnancy. Food and Nutrition Board. Washington DC: National Academy Press; 1990.
• [31]Blumsohn A, Herrington K, Hannon RA, Shao P, Eyre DR, Eastell R: The effect of calcium supplementation on the circadian rhythm of bone resorption. J Clin Endocrinol Metab 1994, 79:730-735.
• [32]Osterberg L, Blaschke T: Adherence to medication. N Engl J Med 2005, 353:487-497.
• [33]Hanson DA, Weis MA, Bollen AM, Maslan SL, Singer FR, Eyre DR: A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992, 7:1251-1258.
• [34]Garnero P, Delmas P: Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease. J Clin Endocrin Metab 1993, 77:1046-1053.
• [35]Van Straalen JP, Sanders E, Prummel MF, Sanders GT: Bone alkaline phosphatase as indicator of bone formation. Clin Chim Acta 1991, 201:27-33.
• [36]National Institutes of Health: Osteoporosis prevention, diagnosis, and therapy. NIH Consensus Statement Online 17th edition. 2000, 1-36. http://consensus.nih.gov/2000/2000Osteoporosis111html.htm webcite
• [37]Della Martina M, Biasioli A, Vascotto L, Rinuncini D, Adorati Menegato A, Liva S, Londero AP, Driul L, Marchesoni D: Bone ultrasonometry measurements during pregnancy. Arch Gynecol Obstet 2010, 281:401-407.
• [38]Hellmeyer L, Ossendorf A, Ziller V, Tekesin I, Schmidt S, Hadji P: Quantitative ultrasonometry of the phalanges during pregnancy: a longitudinal study. Climacteric 2006, 9:446-451.
• [39]To WW, Wong MW, Leung TW: Relationship between bone mineral density changes in pregnancy and maternal and pregnancy characteristics: a longitudinal study. Acta Obstet Gynecol Scand 2003, 82:820-827.
• [40]Hernandez-Avila M, Romieu I, Parra S, Hernández-Avila J, Madrigal H, Willett W: Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica Mex 1998, 40:133-140.
• [41]Rosen CJ, Chesnut CH 3rd, Mallinak NJ: The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation. J Clin Endo Metabol 1997, 82:1904-1910.
• [42]Jarjou LM, Sawo Y, Goldberg GR, Laskey MA, Cole TJ, Prentice A: Unexpected long-term effects of calcium supplementation in pregnancy on maternal bone outcomes in women with a low calcium intake: a follow-up study. Am J Clin Nutr 2013, 98:723-730.
• [43]Prins SH, Jørgensen HL, Jørgensen LV, Hassager C: The role of quantitative ultrasound in the assessment of bone: a review. Clin Physiol 1998, 18:3-17.
• [44]Knapp KM: Quantitative ultrasound and bone health. Salud Publica Mex 2009, 51(Suppl 1):S18-S24.
• [45]Trimpou P, Bosaeus I, Bengtsson BA, Landin-Wilhelmsen K: High correlation between quantitative ultrasound and DXA during 7 years of follow-up. Eur J Radiol 2010, 73:360-364.
• [46]Bonjour JP, Chevalley T, Ferrari S, Rizzoli R: The importance and relevance of peak bone mass in the prevalence of osteoporosis. Salud Publica Mex 2009, 51(Suppl 1):S5-S17.
• [47]Jones G: Early life nutrition and bone development in children. Nestle Nutr Workshop Ser Pediatr Program 2011, 68:227-233.
• [48]Cooper C, Harvey N, Cole Z, Hanson M, Dennison E: Developmental origins of osteoporosis: the role of maternal nutrition. Adv Exp Med Biol 2009, 646:31-39.
• [49]Johnson MA: High calcium intake blunts pregnancy-induced increases in maternal blood lead. Nutr Rev 2001, 59:152-156.
• [50]Harvey NC, Holroyd C, Ntani G, Javaid K, Cooper P, Moon R, Cole Z, Tinati T, Godfrey K, Dennison E, Bishop NJ, Baird J, Cooper C: Vitamin D supplementation in pregnancy: a systematic review. Health Technol Assess 2014, 18:1-190.
• [51]Diogenes ME, Bezerra FF, Rezende EP, Taveira MF, Pinhal I, Donangelo CM: Effect of calcium plus vitamin D supplementation during pregnancy in Brazilian adolescent mothers: a randomized, placebo-controlled trial. Am J Clin Nutr 2013, 98(1):82-91.
• [52]Thomas M, Weisman SM: Calcium supplementation during pregnancy and lactation: effects on the mother and the fetus. Am J Obstet Gynecol 2006, 194:937-945.
• [53]Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L, Torloni MR: Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2014, 6:CD001059. doi: 10.1002/14651858.CD001059.pub4
• [54]Imdad A, Jabeen A, Bhutta ZA: Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: a meta-analysis of studies from developing countries. BMC Public Health 2011, 11(Suppl 3):S18. BioMed Central Full Text
• [55]Hofmeyr GJ, Belizán JM, von Dadelszen P, Calcium and Pre-eclampsia (CAP) Study Group: Low-dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary. Br J Obstet Gynaecol 2014, 121:951-957.
• [56]Patrelli TS, Dall’asta A, Gizzo S, Pedrazzi G, Piantelli G, Jasonni VM, Modena AB: Calcium supplementation and prevention of preeclampsia: a meta-analysis. J Matern Fetal Neonatal Med 2012, 25:2570-2574.
• [57]Ettinger AS, Lamadrid-Figueroa H, Téllez-Rojo MM, Mercado-García A, Peterson KE, Schwartz J, Hu H, Hernández-Avila M: Effect of calcium supplementation on blood lead levels in pregnancy: a randomized placebo-controlled trial. Environ Health Perspect 2009, 117:26-31.
• [58]World Health Organization: Calcium Supplementation in Pregnant Women. Geneva: World Health Organization; 2013.